CJC-1295 is not an FDA-approved drug for anti-aging, body composition, muscle building, fat loss, or general wellness
In the advanced stages of liver disease, when hepatic metabolism and drug clearance are affected, safety is a concern, and plasma levels of estrogen can be elevated (146)
In its lawsuit, the OFA said that the FDAs decision to end the shortage was a reckless and arbitrary move and could deprive patients of a vital treatment for type 2 diabetes and obesity. In an interview with BioSpace last month, David Rosen, partner at Foley & Lardner, said that the lawsuit is a precedent in this area. Prior to the OFA suit, no one has ever challenged the FDAs decision to remove a therapy from the drug shortage list. The OFA case is still ongoing, with the next court update due on Thursday
Post-Blood Draw Side Effects In some cases, blood draws can cause various side effects such as: Swelling at the injection site